Loading people...
Julian Harris is an Operating Partner at Deerfield Management and the Chairman and CEO of ConcertoCare, based in New York. In his executive capacity, he recently led ConcertoCare through a $105 million Series B funding round to expand its technology-enabled senior care services. Previously, he served as the Founding President of CareAllies at Cigna, where he managed a $500 million technology and innovation portfolio before transitioning into healthcare venture capital. His extensive public sector leadership includes overseeing $1 trillion in federal healthcare spending at the White House Office of Management and Budget and directing the $11 billion Massachusetts Medicaid program. Holding a medical degree from the University of Pennsylvania and an MBA from the Wharton School, Harris focuses his current efforts on bridging clinical medicine, government policy, and private investment to scale value-based healthcare models.
Julian Harris is a distinguished Partner at Deerfield Management, a healthcare investment firm renowned for its deep expertise and significant contributions to advancing medical innovation. At Deerfield, Julian plays a pivotal role in identifying, evaluating, and investing in companies that are at the forefront of scientific discovery and healthcare solutions. His work directly supports Deerfield's mission to accelerate the development of new treatments and technologies that address unmet medical needs.
Julian's investment focus at Deerfield Management spans a broad spectrum of the healthcare industry, with a particular emphasis on life sciences, biotechnology, and medical technology. He is keenly interested in companies developing novel therapeutics, diagnostics, and devices that have the potential to significantly improve patient outcomes. His portfolio often includes early stage ventures with promising scientific platforms, as well as more established growth stage companies seeking to scale their impact. Julian's approach combines rigorous scientific due diligence with a strategic understanding of market dynamics and regulatory pathways, ensuring that Deerfield's investments are both scientifically sound and commercially viable.
Prior to his tenure at Deerfield Management, Julian Harris built a robust career foundation within the healthcare and finance sectors. He gained extensive experience in venture capital and private equity, where he honed his skills in deal sourcing, valuation, and portfolio management. His background also includes roles in strategic consulting for pharmaceutical and biotech companies, providing him with a comprehensive understanding of the operational challenges and opportunities within the industry. This diverse experience has equipped Julian with a unique perspective, enabling him to effectively partner with management teams to navigate complex development cycles and bring innovative products to market.
While specific investment details are often confidential, Julian's work at Deerfield has contributed to the growth of numerous impactful companies. Examples of the types of investments he champions include biotech firms developing gene therapies for rare diseases, medical device companies creating next generation surgical tools, and digital health platforms enhancing patient care coordination. His commitment to fostering innovation and supporting entrepreneurial vision underscores his reputation as a key figure in healthcare investment.
Julian Harris is a Partner at Deerfield Management, a leading healthcare investment firm. He is known for his expertise in identifying and investing in innovative companies across the life sciences, biotechnology, and medical technology sectors.
Julian Harris primarily invests in companies within the healthcare sector, with a focus on life sciences, biotechnology, and medical technology. He seeks out firms developing novel therapeutics, diagnostics, and devices that address significant medical needs.
Julian Harris works as a Partner at Deerfield Management, a prominent healthcare investment firm dedicated to advancing medical innovation and improving patient outcomes.
